Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MDP.TO Relative to the S&P 500

MDP.TO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Medexus Pharmaceuticals Inc. (TSE:MDP.TO) seasonal charts above shows that a Buy Date of June 2 and a Sell Date of August 25 has resulted in a geometric average return of 13.94% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 31.17% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful?North American commercial platform and a growing portfolio of inventive?and rare disease treatment solutions. The company’s focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

To download MDP.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MDP.TO